Reuters logo
BRIEF-Dow Chemical updates on patent dispute with Bayer
February 9, 2017 / 2:42 PM / 7 months ago

BRIEF-Dow Chemical updates on patent dispute with Bayer

Feb 9 (Reuters) - Dow Chemical Co

* Dow Chemical - In January 2017, the USPTO issued final office actions for two of the patents asserted in a case, including the ‘962 patent

* Dow Chemical - USPTO rejected all relevant claims related to a patents dispute with Bayer, based on the doctrine against double-patenting

* Dow Chemical - Re-examination proceedings with respect to other two patents remain pending, although co anticipates that USPTO will likewise invalidate those patents

* Dow Chemical - Although Bayer may appeal these decisions, co believes USPTO final office actions will provide a strong basis to vacate the arbitral award

* Dow Chemical - As part of the co's review of the arbitral award, co assessed the legal and factual circumstances of the case Source text: (bit.ly/2k7aYGP) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below